Training future researchers in aging and Alzheimer's disease
Aging and Alzheimer's Research Training
['FUNDING_TRAINING'] · GEORGETOWN UNIVERSITY · NIH-10911891
This program at Georgetown University is designed to help new researchers learn about aging and Alzheimer's disease, so they can better understand and find ways to improve the lives of people affected by these conditions.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGETOWN UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-10911891 on ClinicalTrials.gov |
What this research studies
The Aging and Alzheimer's Research Training program at Georgetown University focuses on educating predoctoral and postdoctoral fellows who lack prior training in aging or Alzheimer's disease. This program integrates various biomedical fields related to cognitive impairment in aging, such as diabetes and traumatic brain injury. Trainees will engage in clinical exposures, coursework, grant writing, and collaborative research efforts to enhance their understanding and skills in this critical area. The program aims to foster a new generation of researchers dedicated to advancing knowledge in aging and Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in pursuing careers in aging and Alzheimer's research, particularly those who are predoctoral or postdoctoral fellows.
Not a fit: Patients who are not involved in academic or research training programs may not directly benefit from this research.
Why it matters
Potential benefit: If successful, this research training program could lead to improved understanding and treatment of Alzheimer's disease, ultimately benefiting patients and their families.
How similar studies have performed: Similar training programs have shown success in enhancing research capabilities and advancing knowledge in related fields, indicating a positive outlook for this initiative.
Where this research is happening
WASHINGTON, UNITED STATES
- GEORGETOWN UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: REBECK, G WILLIAM — GEORGETOWN UNIVERSITY
- Study coordinator: REBECK, G WILLIAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease